Mad Money w/ Jim Cramer 2/24/26

Summary

Mad Money w/ Jim Cramer – Episode Summary
Air Date: February 25, 2026

---

Episode Overview

In this engaging episode of Mad Money, Jim Cramer takes listeners through the rollercoaster dynamics of current market trends, the rise of new investing acronyms like “HALO,” the disruptive impact of artificial intelligence (AI)—particularly Anthropic—on legacy industries, and detailed analysis of select stocks. Special attention is paid to the fundamentals of companies seeing extreme demand, notably in the AI hardware and infrastructure supply chain, as well as a deep dive into animal health company Elanco, the fintech sector, and a review of volatile movers like Bloom Energy. The episode concludes with Cramer’s expert perspective on the turmoil facing enterprise software stocks due to accelerating AI disruption.

---

Key Discussion Points & Insights

1. The Market’s Obsession: HALO and Its Misconceptions

[01:41-05:50]

• HALO: A new Wall Street acronym — "Heavy Assets, Low Obsolescence”.
• Cramer critiques the simplicity of this framework, noting the real investor desire is:

  “We want companies that make things and do stuff that we can understand.”
  (Jim Cramer, 03:32)

• Recent market action saw a rotation: old tech/software stocks sold off, while tangible-product manufacturers surged.
• He calls out the market’s overreaction to AI-generated press releases from companies like Anthropic, suggesting market participants are “almost eager for a reason to dump” complicated, less tangible business models.
• Notable quote:

  "If you can't explain the business to someone else, you can't own it."
  (Jim Cramer, 05:44)

---

2. AI Disruption, Memory Shortages & Hardware Winners

[05:51-09:53]

• Memory device manufacturers (SanDisk, Western Digital, Seagate, Micron) are “rationing supply” due to insatiable AI-fueled demand.

• The AI boom leaves massive shortages for memory and storage as tech giants hastily expand data capacity.

• Semiconductor equipment suppliers (KLA, Teradyne) also benefit from this trend.

• Warns the shortage "isn't orchestrated" and "won't resolve quickly" because it’s about the time to expand, not just capital.

• Only Nvidia’s Jensen Huang seemed to predict this “ocean of demand.”

• Cramer’s bottom line:

  “We want companies that have so much demand that they have to ration out their product to customers because there’s not enough capital equipment to expand memory production. These machines take a long time to build… The shortage likely won’t end anytime soon.”
  (Jim Cramer, 07:50)

• Other Stock Themes Mentioned:

  • Energy (e.g., Caterpillar for turbines)
  • Retail value stores (Walmart, Dollar General, Costco, Dollar Tree, TJX)
  • Consumer staples (Johnson & Johnson, Colgate, Procter & Gamble, Hershey)
  • Understandable, demand-driven businesses over abstract business models

• Humorous reflection:

  “Anthropic right now is in my vagus nerve…threatening my whole cerebellum.”
  (Jim Cramer, 09:47)

---

3. Lightning Round Call-Ins

[09:54-12:31]

• Robert from New York: Praised Cramer’s book and tracked a successful call on Generac—which Cramer playfully nudges as “cherry picking,” but agrees the shift from a consumer to business-to-business focus was critical.
• Cramer’s buy/hold/sell opinions on various stocks; recurring theme: favoring companies that make tangible things and serve visible, high-demand markets.

---

4. SoFi Technologies: A Victim of the AI Displacement Thesis

[14:24-21:17]

• Cramer revisits SOFI after a sharp pullback, declaring the stock "too cheap to ignore" at $18 post-selloff.
• Reinforces SoFi's core strength: it's a bank, not an easily-displaced tech firm.
• Fundamentals:
  • 37% revenue growth, 160% earnings growth YoY
  • Consistent overachievement on guidance
  • Robust product cross-selling, expanding member base (now 13.7 million)
• Cites CEO Anthony Noto’s long-term success, bullish on their medium/long-term growth forecasts:

  “For months now I’ve been telling you SoFi needed to come in…Well, that’s what happened. It pulled back more than 40% from its mid-November highs…The business is strong, the forecast is beautiful. It’s a bank, guys. It has a federal charter. It’s not going to get replaced by Claude or Open Air.”
  (Jim Cramer, 20:42)

• Conclusion:

  “Now I think it is too cheap to ignore.”
  (Jim Cramer, 21:15)

---

5. Bloom Energy: Hype or Real Growth?

[22:52-29:29]

• Bloom Energy’s stock saw an “astonishing” rally (up 1,837% over two years); demand driven by data center buildout.
• Details massive contracts with AEP ($2.65B for 1,000 megawatts of fuel cells), Oracle data centers, Brookfield Asset Management ($5B partnership), and CoreWeave.
• Cramer notes the company is fundamentally stronger than previous cycles and is now consistently profitable.
• Valuation flags: trades at 118x current earnings, 57x 2027 estimates; “not what anyone ever called cheap.”
• Advice:

  “If we get, say, absolutely a 20% pullback, I would feel a lot more comfortable recommending this one.”
  (Jim Cramer, 28:29)

• Memorable nod to pop culture:

  “If you’re questioning whether Bloom Energy’s fundamentals are real, I gotta borrow a line from the legendary Teri Hatcher in Seinfeld. They’re real. And they’re spectacular.”
  (Jim Cramer, 29:22)

---

6. Elanco Animal Health: CEO Interview

[31:42-39:44]

• Guest: Jeff Simmons, CEO, Elanco Animal Health

• Elanco has transitioned into a “sustainable growth company” post-Lilly spinout, focusing on growth, innovation, and cash flow.

• 12% revenue growth, strong quarters, six newly-approved blockbuster products.

• Key brands:

  • Parasiticides (tick, flea, heartworm prevention): Market leader with new product Credelio Quattro.
  • Dermatology: Zenrelli (for itching dogs), Befrena (targeting monoclonal antibodies), both driving share.
  • Protein revolution: Elanco is #1 in beef/poultry/swine health products; riding higher beef and dairy demand due, in part, to the “muscle retention” health trend.

• Globalization and Convenience:

  • 70% of puppy sales now outside of US.
  • 40% of pet care is under subscription; Elanco well-positioned via omni-channel reach and Bayer acquisition.

• Quote:

  “If you get the puppy, you keep the dog.”
  (Jeff Simmons, 34:39)

  “The humanization of pets is globalizing, Jim…We’re best set up as any company to take advantage of that.”
  (Jeff Simmons, 38:09)

---

7. Lightning Round: Buy/Hold/Sell Rapid Fire

[40:06-43:05]

Several notable moments:

• Kyndryl (KD): “Had some accounting issues…too early to recommend.” (41:09)
• Novo Nordisk: “You want to be like Lilly. Novo Nordisk’s really good at cutting prices. Eli Lilly’s great at making drugs.” (41:29)
• Gartner: “Not a great quarter…people worried about Anthropic going after them. Have to say no.” (42:08)
• Powell Industries: “Take off one third…then you’re playing with the house’s money.” (42:49)

---

8. Closing Analysis: The AI Shockwave Through Software

[43:20-47:40]

• Cramer analyzes the collapse of enterprise software’s “untouchable” status.
• Legacy metrics ("rule of 40," recurring revenue, sticky contracts) have faltered under the threat of automated AI code-writing.
• Anthropic’s public pressure (through press releases) spooks customers from committing to long-term software contracts—damaging industry multiples and hurting PE/VC firms exposed to these models.
• Pain likely to persist:

  “There’s way too much money in the enterprise software space…and way too many companies now being disrupted by AI…My forecast for all is pain and the losses are far from over. So use this bounce to lighten up.”
  (Jim Cramer, 47:25)

---

Notable Quotes & Timestamps

• “We want companies that make things and do stuff that we can understand.” – Jim Cramer, 03:32
• “If you can't explain the business to someone else, you can't own it.” – Jim Cramer, 05:44
• “We want companies that have so much demand that they have to ration out their product...” – Jim Cramer, 07:50
• “Now I think [SoFi] is too cheap to ignore.” – Jim Cramer, 21:15
• “They’re real. And they’re spectacular.” (on Bloom Energy fundamentals) – Jim Cramer, 29:22
• “If you get the puppy, you keep the dog.” – Jeff Simmons, 34:39
• “The humanization of pets is globalizing, Jim.” – Jeff Simmons, 38:09
• “My forecast for all is pain and the losses are far from over.” – Jim Cramer, 47:25

---

Timestamps for Important Segments

• [01:41] – Cramer’s Market Overview and HALO Critique
• [05:51] – AI, Memory Shortages, Hardware Winners
• [09:54] – Lightning Round Begins (callers on Generac, etc.)
• [14:24] – SOFI Technologies Deep Dive
• [22:52] – Bloom Energy Analysis
• [31:42] – Interview with Elanco Animal Health CEO
• [40:06] – Lightning Round Rapid Fire
• [43:20] – Enterprise Software & AI Disruption Analysis

---

Tone & Style

Cramer’s usual fiery, irreverent, and direct delivery prevails. He mixes data-rich analysis with colorful analogies, humor, and engaging dialogue, both with callers and his guest.

---

Final Takeaways

• Investors should prioritize businesses that are tangible, transparent, and experiencing real, inelastic demand—especially suppliers of AI infrastructure, essential consumer goods, and pet health.
• Beware of “thematic” rotations and buzzwords like HALO that oversimplify market drivers.
• Enterprise software faces significant disruption as AI fundamentally threatens previous business models and revenue assumptions.
• Use present “relief rallies” to trim positions in exposed sectors, and favor stocks with demonstrable, understandable value and pricing power.

---

For more, see the detailed caller interactions, full CEO interviews, and Cramer’s classic Lightning Round—each packed with crowd-pleasing insight and actionable commentary.

Transcript

[Advertiser/Commercial Announcer]

Hiring isn't just filling a role, it's about finding people who can drive results. Indeed Sponsored Jobs helps you match with the right candidates faster. Target candidates by skills, certifications or location. Join the 3.3 million employers worldwide that use Indeed to connect with quality talent that fits their needs. And listeners of this show will get a $75 sponsored job credit to help get your job the premium status it deserves@ Indeed.com podcast terms and conditions apply. Hiring do it the Right way with

[Homes.com Representative]

indeed, homes.com knows that when it comes to home shopping, it's never just about the house or condo. It's about the home. And what makes a home is more than just the house or property. It's the location and neighborhood. If you have kids, it's also schools, nearby, parks and transportation options. That's why homes.com goes above and beyond to bring home shoppers the in depth information they need to find the right home. And when I say in depth, I'm talking deep. Each listing features comprehensive information about the neighborhood, complete with a video guide. They also have details about local schools with test scores, state rankings and student to teacher ratio. They even have an agent directory with the sales history of each agent. So when it comes to finding a home, not just a house, this is everything you need to know all in1place.homes.com We've done your homework.

[Jim Cramer]

Hey, I'm Kramer. Welcome to Mad Money. Welcome to Kramerica. Other people, my friends. Hey, I'm trying to make a little bit of money here. My job is not just to entertain you but to educate, teach you. So call me at 1-800-743-CNBC at tweet. Mitchim Kramer why does Wall street have to make things so darn hard? Right now, with the entire market turning against the once beloved software companies and the old Magnificent Seven, we got this new silly term to express what investors have allegedly fallen in love with. It's called Halo which means heavy assets, low obsolescence. Today the market look for Hal halo where ever it could find it. And the hunt produced solid results with the Dow gaining 370 points as we jumping.7% and NASDAQ advancing 1.04%. Now today was a recovery where we saw buyers for everything. Why? Because we're getting oversold. Too much buying pressure on Halo, too much selling pressure on the new to spy software companies. What's really going on here? Are we honestly looking for companies with low obsolescence? No. Do you really care about heavy assets? If that were true, how do you explain the strength of Consumer packaged goods stocks like PepsiCo, P&G J&JJ and Colgate. They're the hotties. I think the HALO acronym misses the point entirely. What do we really want? Well, we want companies that make things and do stuff that we can understand. We want to avoid stuff we can't or don't comprehend. The because you can't get your head around it. That is probably the kind of stock that Anthropic can knock off, can wreck with a simple press release. And you better believe that release will come out. Because as good as Anthropic is at creating agents that write code, it is even better at writing press releases that target specific industries. It may be the best I've ever seen. I mean perhaps they're so important that humans write them. Anthropic introduces disruptive press releases in an aggressive cadence and they make it sound like Anthropic is going to wreck whole sectors, taking with them the investors in the companies and those that lent the money, destroying slap happy private equity and private landing outfits left and right. Now they're having a spat with the Department of War. Oh, I hope Anthropic leaves the Department of War intact. It's useful. Yesterday Anthropic put out something that sounded like it could hurt IBM and IBM stock lost over 13% like this. It was one of the worst declines in ages. I IBM has the same problem as the hard hit enterprise software cohort. It's difficult to understand because some of its businesses are complicated. It was an astonishing decline for a company that is actually doing quite well. Unfortunately all the sellers need to know is that there's a successful software company or in the case of IBM, a hardware company sells software. Anthropic will mimic it for less money, but just using its AI, customers will pause their purchases to see what Anthropic can do with or maybe just ask vendors for shorter contracts for less money. Either way it's bad news. Could free some IBM business. I guess people think that suddenly once unassailable companies with great moat seem like they might might be worth nothing. Yes, nothing. Maybe these software stocks can have periodic bounces. But if you don't know what they do, if you don't know what they make, if you can't explain the business to someone else, you can't own it. The bounces are all relief rallies. A few days of hours reprieve for more selling. They caused the stocks of private equity companies that are invested in disruptive industries to bounce too. I mean Workday had a relief rally today, but then it reported disappointing numbers after the close out. No relief for you workday. You should sell the bounces because they're temporary. I say all hell. Anthropic, the destroyer of everything. At least that's the storyline that they're telling. And now Wall street believes in it. Now let me tell you why. Halo is funny, but too abstruse and stupid for us to use. We don't really want stocks of companies with heavy assets and low obsolescence. Give me a break. We want the stocks of companies that make products that are in short supply that people want have heavy demand. It just so happens that the companies which make the most in demand products in the world are companies that make memory devices for every kind of technology, especially artificial intelligence. There are four of these. Sandisk, Western Digital, Seagate and Micron. These are companies that have to allocate orders carefully because they have so little product memory prices can skyrocket and customers have no choice but to pay up because AI data needs to be processed and stored. There won't be a price where these memory and storage products do get too expensive, but we don't know what or where those prices are. How high, how big, I don't know. There's been no demand destruction of any real kind because this stuff is essential. These stocks go up every day before the market opens because the buyers simply can't wait until 9:30. I've never seen anything like it in my career. Now someone did put out a report today saying the dump Sandisk might give you a good chance to buy some. I inclined to take it. Watch it start going up at around 9 o'. Clock. Second most powerful theme again a technology theme. The semiconductor capital equipment companies that make the machines needed to boost memory and storage production. There are only half of these, think Klam. And then there are other companies that test what these companies make. Again, only a handful. I like Teradyne. This memory storage is the most severe shortage I have ever seen in my career. It was not orchestrated by design. It occurred because the CEOs in the supply chain was were caught flat footed by the flood of data and didn't believe that the data center demand could be so insatiable. They'd been surprised positively before, only to be crushed when a ton of supply came in online to meet the new demand. Not one of these companies foresaw this data center explosion or the power of AI. Frankly nobody in the industry did. Except for of course one person, Jensen Huang, the CEO of Nvidia, which reports tomorrow. By the way, he did tell anyone who would listen that the shortage would occur. So I don't blame the memory makers for holding back on adding capacity. They've been burned too many times before when demand eventually dried up. This time it's not drying up. It's an ocean of demand. We want companies that have so much demand that they have to ration out their product to customers because there's not enough capital equipment to expand memory production. And these machines take a long time to build. The shortage likely won't run anytime. It's just not going anytime soon. By the way, it's not about money. It's about time. The time it takes to make the stuff. Many bears say it can't last and there are a ton of them. The bears always come out of the woodwork when your stocks are red hot for a long time. They're betting one of the big hyperscalers of the clients will pull back and stop spending. But with big deals like the $100 billion order met a place with AMD this morning. You better believe they're going to need all the memory and storage they can get. Now. I keep hearing about Halo names they were supposed to like energy. Fine, but there's a lot of energy out there. Hamburgers, I mean, huh? Have you looked at beef prices? Steel? Not if the tariffs go away. How about health care? Just the distributors. Anything in finance? Right now we're hearing that finance will be destroyed when white collar jobs are destroyed by AI. Until we find out that's not possible, people get a little more positive. You got to stay away from that group. Skip it. What else do we need so badly that will pay anything for? Well, how about Caterpillar? We like their stuff. Turbines for Nova. Hey, how about things that move? Other things FedEx is good of have a value oriented. Any trucker have a value or a company like Wal Mart, Dollar General, Costco, Dollar Tree, tjx, they report tomorrow. All those companies make things and sell them cheaper than the other guys. You know what Johnson Johnson's good. Colgate, Procter and Gamble, Hershey. Don't think Halo. Think understandable things. The bottom line. I know it's a small list but they all make things and do stuff we can understand. They're all on demand. There are others? I can't think of them right now. That's because anthropic right now is in my vagus nerve right here and it's threatening my whole cerebellum right here. So let me get back to you. Let's go to Robert. New York, please. Robert.

[Caller/Listener]

Jim, I'VE got to tell you this. It's so nice to hear your voice and it's so great to be on the number one show in the country, number one business show in the country. And I want to tell the listeners that you made me money again. And they have to go out tonight and buy the book. How to make money in any market. Go to Kindergarten should have this as a must read. Business school should have this as a must read. I want every listener in America to go out and buy Kramer's book. And you will make money in any market.

[Jim Cramer]

Okay, Robert, that was the $10,000 one. Can I have the $15,000 endorsement now? Just kidding. I know you speak from the soul, you speak from the song.

[Caller/Listener]

All right, thank you. Okay, let's get to work.

[Jim Cramer]

Jen. This next stock,

[Caller/Listener]

this next stock has been on fire year to date. The stock is up over 72% and I think it's going much higher. There are manufacturer of power generation products for residential, commercial and industrial markets. Their CEO is very, very solid. But here's the kicker. The potential revenues for generators for the AI not to mention the acquisition of Enercon, will bolster this company's manufacturing capabilities for AI the board has announced a new share repurchase program with the buyback of 500 million shares. Now let's go to the videotape, ladies and gentlemen. Jim Cramer said on September 24 When I called him, Robert, you've got to hold this stock. This is a good company. And it was 167. And you know where it is now, ladies and gentlemen, $235 a share generate.

[Jim Cramer]

All right, well, blind squirrel finds not. I got to add that because he's cherry picking. Of course it wasn't me. I will tell you this. What happened is it was a business consumer company and people got a little waylaid because of how much it cost to be able to borrow money. It's become a business to business. When it became business to business, it went to the moon. And I tell you now, it's going to the stars. And I want to thank Robert Dowsey. He was a touching testimonial. We want companies that make things and do stuff we do not want. Halo. Halo. We want good stuff. It's in demand. Only money tonight so far has been taken down with its broader AI solo. But is it warranted? Then we're looking learning that building data centers is a lot more expensive than we thought. So who could benefit from this development? I'll reveal the name of an energy company that I think you should keep an eye on and animal health care Elanco struggling to gain traction following the 2018 spin off from Eli Lilly, but now it's really coming together. I'm going to get the state of play from the CEO himself, so stay with Kramer.

[Show Producer/Host Voiceover]

Don't miss a second of Mad Money. Follow imkramer on X. Have a question? Tweet Kramer Madmentions. Send Jim an email to madmoneynbc.com or give us a call at 1-800-743-CNBC. Missed something? Head to madmoney.cnbc.com

[Advertiser/Commercial Announcer]

Financial growth begins long before the first investment. It comes from understanding what you're building toward, what's at stake, and what success looks like for you. At Oppenheimer, we bring bold thinking, guided by the full strength of our expertise to put capital to work building and protecting wealth that lasts generations. Put the power of Oppenheimer thinking to work for you. Wealth Management Capital Markets Investment Banking

[Jim Cramer]

Comcast Business helps retailers become seamlessly restocking, frictionless paying favorite shopping destinations.

[Jeff Simmons, CEO of Elanco Animal Health]

It's how nationwide restaurants become touchscreen ordering,

[Jim Cramer]

quick serving eateries and how hospitals become the patient scanning data managing healthcare facilities

[Jeff Simmons, CEO of Elanco Animal Health]

that we all depend on.

[Jim Cramer]

With leading networking and connectivity, advanced cybersecurity and expert partnership, Comcast Business is powering the engine of modern business, powering possibilities. Restriction Supply how can you free your

[Homes.com Representative]

team from time consuming office tasks? Amazon Business empowers leaders to not only streamline purchasing, but better support their teams. Smart business buying tools enable buyers to find and purchase items fast so they can focus on strategy and growth. It's time to free up your teams and focus on your future. Learn more about the technology, insights and Support [e-mail].

[Jim Cramer]

So last night I got this call from Don in Florida. Want to know about SO5 Technologies, the digital bank that tends to trade more like your typical financial tech company. Historically, I've been a big fan of this one and I kept recommending it as a qualifier, late 2024 and the bulk of 2025. Eventually though, the stock got just too hot to handle. So by peak last November and by December, I was telling you to wait for a pullback when it was at 25 and then in January when the stock ticked up to 28, I reiterated that it just needed to come down more before I tell you to buy it. And you know what? Now it has. It's at $18 and change off about 10 bucks from when I said hold off dragged out by the broader AI displacement sell off. We've seen some nasty declines in health Management companies because of the stock brokerage too and former fintech darling. Somehow that's come to include so Far which is now down about 30% year to date. That call from Don in Florida list. I got to tell you, I thought it was worth coming to this one with fresh eyes because at the end of the day so Far is a bank. And banks are not under threat from artificial intelligence. They're consumers of AI, not the prey of it. Think of it like that all times as which they are. It just seems that Wall street hasn't gotten that memo. When so Far reported at the end of January, the stock just got clobbered and it's been falling ever since. But you know what the actual numbers were? Excellent. 37% revenue growth, 160% earnings growth, both higher than expected so Far. Overall membership count grew by 35% year over year. 35% to 13.7 million people. Their net interest income jumped 31%. Fee based revenue was up 53%. I mean this is a great business. It is practically printing money. Now SoFi's guidance for the current quarter came in a little light on on every single line. But look, these guys have a long history of practicing upon which is under promise and over deliver. The company has beaten revenue and EBITDA expectations in each of the last 18 quarters. It's reported coming public in 2021. And it's beaten the earnings estimates for the last nine quarters in a row. That's not shabby. More importantly, when you look at so Far's full year forecast, these numbers are nothing more than sensation for full year. 2026 so far expects total member growth of at least 30%. And with revenue growth coming in at roughly the same level, adjusted EBITDA net income and earnings per share3 are expected to grow by 52%, 71% and 54% respectively as gross margins expand. Now all of those numbers were much better than Wall street was expecting when so Far issued that forecast about three and a half years. Three and a half weeks ago. I mean that's so notice they three and a half weeks and then they just clobber that on top of that so Far issued what it called medium term guidance saying that expects adjusted net revenue to rise at a compound annual growth rate of at least 30% for the next three years. Meaning that through 2028. I love that kind of thing in that time frame. So Far also expects its earnings per share to rise at a 38 to 42% compound annual growth rate. Guys, these are astonishing. There's absolutely nothing hurting this business right now. Which makes it kind of crazy that the stock pulled back from 32 to 18 in the past few months. Again, this is not some throwaway financial technology company that can easily be replaced by it as fast It's a fast growing bank with digital traffic. So I've been recommend recommending a stock all the way back since it was $5. And what caught my attention why I like it so much frankly is its CEO Dan Sterdo. I've known him for almost 30 years when he was a banker helped bring the street.com public in the late 90s because I think this is the he's made this bank into the preferred financial services platform for millennials and gen zers. Nothing I've seen lately has changed that assessment. In fact, I feel like the thesis is just stronger than ever. So Far has phenomenal product growth in the fourth quarter largely because of cross buying, meaning customers take more than one product from these guys. About 40% of new products opened in the fourth quarter were done by existing SO5 members. They're gradually colonizing the consumer banking business. Now consumers increasingly view so Far as a full financial services platform rather than just a purveyor of individual financial products. They might come to so far initially for a personal loan to help pay off credit card debt. But then they find that they like the company's digital banking platform too. Then they find out that so far they found this product called SoFi Invest. That's your self directed brokerage platform. It's pretty good. Or they realize that they might like some of the companies RoboInvestor or ETF Solutions or they might move an IRA account to so far the company's current success with cross selling combined with the robust guidance for not just 2026 but the next three years, I think it tells you all you need to know. Finally, let's let's talk about why I think it's safe to buy so Far right here, right now after its severe pullback, the stock now represents good value down here at $18 and Change Management says they can earn 60 cents per share in 2026, meaning so far is trading at around 31 times this year's earnings forecast. Okay, so let's see. That's not cheap in absolute terms. I know. But you got to remember that so Far is on track to grow earnings at 54% clip this year and to keep growing earnings about around 40% through 2028. Growth oriented money managers like to look at what's known as the PEG ratio PG that's price their earnings to growth growth. And so far it's got a very reasonable PG rates ratio or PEG ratio of just 0.6. The lower the better. With the PEG ratio Paying just over 30 times earnings for a company with a 50% plus growth rate is a legitimate steal. Plus the stock looks outright cheap based on some of the earnings projections for the out years. Looking at Wall Street's earnings estimates so far it sells for around 23 times next year's numbers and just under 19 times the 2028 numbers. But don't forget those estimates again are probably too low. If you believe so far as medium term guidance and I do because I think CEO Anthony Noto does again have that habit of beating the expectations. Then the stocks will trade about 17 times its 2028 earnings forecast. That's really good. Bottom line. For months now I've been telling you that so far stock needed to come in a bit. I was, I was concerned it could drop a lot after its enormous gains of 2024 and 2025. Well, that's what happened. It pulled back more than 4, 40% from its mid November highs coming all the way down to 18 and change. And now I think it is too cheap to ignore. The business is strong, the forecast is beautiful. And when you look at what's been dragging so far stock down the displacement thesis, the stock feels like the proverbial baby that got thrown out with the bathwater. It's a bank, guys. It has a federal charter. It's not going to get replaced by Claude or Open Air. Frankly, if I were one of those two and I wanted to destroy the banking sector, I just buy SoFi. Or at least send out a press release that you plan to buy SoFi. Well, that's all it takes these days they have money's back in pretty quick.

[Show Producer/Host Voiceover]

Coming up. It's still February, but spring may have already sprung for bloom energy. Kramer's picking apart the numbers to see if the stock can stay fertile.

[Jim Cramer]

Next, when I lost my sight, I found a way to win bank of America champions blind soccer player and coach Antoine Craig and everyone who dares to

[Advertiser/Commercial Announcer]

ask, what would you like the power to do?

[Jim Cramer]

Bank of America Proud to be the

[Advertiser/Commercial Announcer]

Official bank of FIFA World Cup 2026

[Jim Cramer]

bank of America NA Member FDSE at

[Advertiser/Commercial Announcer]

Strayer University we help students like you go from will I to why not? For over 130 years we've been innovating higher education to make it more affordable, accessible and attainable so you can reach your goals. Go from thinking can I to yes I can and keep striving. Visit strayer.edu to learn more. Strayer University is certified to operate in Virginia by Chev and its many campuses, including at 2121 15th Street north in Arlington, Virginia. When I need to impress someone with a gift, I go straight to 1-800-FLOWERS. There's a reason they've spent 50 years as the floral authority. Every stem is hand selected by a vetted florist and with same day delivery nationwide, 100% satisfaction guaranteed. That's why millions go to 1-800-Flowers to celebrate life's most important moments. Order now for up to 40% off. Don't miss out on this limited time offer. Act now and save up to 40% at 1-800-flowers.com sxm. That's 1-800-flowers. Com sxm.

[Jim Cramer]

Over the last few months, we've learned that building data centers might be a lot more expensive than the hyperscalers were expecting. That's not ideal for big tech, but it's for the companies that supply equipment or keep these warehouses full of servers running. I want you to consider a company called Bloom Energy. We've talked about them. They make solid oxide fuel cell systems that can supply clean energy right at the place where it needs to be the most. Their fuel cells take hydrogen, or more commonly natural gas than break them down through an electrochemical process without combustion. Without combustion to create electricity. The hydrogen ones are clean and the natural gas ones are ideal for carbon capture because they don't actually burn anything so well, you know what? Green still matters. People think of it as a perfect backup power generation system for when the grid does go down. That's why the stock is up in astonishing rate 1837% over the past two years, including a nearly 600% gain since last June and a 91% gain year to date. But whenever you see a stock rally like that, you have to wonder if the real is it the real deal? Especially when we see this kind of move before, right? I mean think about see, Bloom Energy came public almost eight years ago at 15 bucks and quickly ran up to 38 in September 2018 before reversing and then spending the next year going lower. Eventually the stock bottom $2 and changed in 2019 that its stock soared during the COVID year bull market flying to 45 in February of 2021 only to roll over again, ultimately sinking to about eight bucks at its lows a couple of years ago. Bloom then caught fire thanks to the rise of the data center racking up some magnificent gains. Now, of course, the stock got hit hard when the data center trade cooled off last year, late last year, remember getting cut in half early November through mid December. Since then, though, the stocks come roaring back and it's now well above last year's highs. Now, I've got to tell you, I think this one's legit. I just don't know if it's too legit to quit. Bloom Energy's latest rally is not like what we saw in 2018 or 2020. This company has announced a series of major deals with a set of very legitimate partners. Data center operators are desperate for on site power solutions solutions. And this is a tested technology. Wal Mart, Google, FedEx, they've been using Bloom fuel cells for years. What changed is that demand for them is now off the charts. In late 2024, Bloom announced a deal with American Electric Power, the Ohio based electric utility that operates America's largest power transmission network. AP does electricity better than anyone and they wouldn't work with a company that's more of a science project than a legitimate player. At the time the announcement, AOP AP ordered 100 megawatts of fuel cells from Bloom Energy with the option to buy another 900 megawatts. They wanted to at that original announcement, an Ohio regulator greenlit a project among ap, Bloom and Amazon Web Services last summer. And just at the beginning of the year, AP disclosed that it's buying the full thousand megawatts of fuel cells from Bloom for 2.6 billion. $2.65 billion. I mean talk about it now. Last July, Bloom Energy announced a deal to deploy fuel cell technology at select Oracle data centers. And it's got a great partnership with Core Weave too, dating back to 2024 when Corby was a company most people hadn't even heard of. They're one of the. They really are one of the best at building data centers around. So their endorsement, Core Weaves endorsement carries a lot of weight. What else? Last October, Bloom announced a $5 billion partnership with Brookfield Asset Management. Now that's an investment firm that specializes major infrastructure products including data centers. That is a huge endorsement. Brookfield might be the savviest of datacenter creator financiers. I really have come to really like these guys. If they if Bookfield says they're good, they're good. Of course, this story is not just about contracts. Source about sales, earnings. I wouldn't be so confident about Bloom if the numbers weren't excellent. Bloom Energy first term profitable. It's profitable in 2024 reporting $0.28 earnings per share. Then last year their earnings tripled to well, nearly triple to $0.76. We found out that the final result for 2025 about two and a half weeks ago on February 6th, when the company delivered a stunning set of fourth quarter numbers, Bloom posted a massive revenue beat. While their earnings came in at 45 cents per share. I mean, the analysts were looking for 31. More importantly, Bloom's new full year forecast was much, much better than anyone expected. They guided for 3.1 to 3.3 billion in sales. Wall street was just looking for 2.2, 2.55 billion and said to expect the earnings to go to $33 to a $48. You know, people are looking for a buck 11. This may be one of the best beats of the year. In other words, after Bloom turned profitable in 2024, then their earnings nearly tripled last year. They should roughly double again this year. The stock's been flying because that big AEP purchase order and this unbelievably strong quarter. All that said, while Bloom Energy has become phenomenal growth story, that doesn't necessarily mean the stocks were buying here. We got to, we got to like suss this out a little. But when I first covered this story back in September, I admit that I said the same thing, wait for a pullback. But that turned out to be way too cautious. The stock was only at 73 at the time and you would have more than doubled your money if you bought it there. I heaped a ton of praise on the company, but the stock had already run so much I was afraid free to pull the trigger. Still today, Bloom rallied another 3.7% at 166 is trading 118 times the midpoint of this year's earnings forecast. If you're willing to use the estimates for the out years, the Stock sells for 57 times 2027, 36 times 2028. That's more reasonable, but it's not what anyone ever called cheap. Besides, a lot can happen between now and 2028. Plus, don't forget Bloom is incredibly volatile stock market. There's a pretty good chance that we get another pullback here. One that gives you a better, more palatable entry point. Sure, this stock's had a stunning rally over the past few months. That was in part because of short covering. And at this point, I'm betting most of short covering has run its course. At the same time, it'll become harder and harder for Bloom to surprise to the upside simply because when you keep Beating the numbers. The analysts finally get wise here and they take the numbers up really big. Last time, Bloom had a big pullback. In the final month of 2025, the stock fell almost 50% and of course, 5 out of 10 in just over a month. Of course, I don't think that can bank. You can bank on that happen again. But if we get say absolutely a 20% pullback, I would feel a lot more comfortable recommending this one. Bottom line here, if you're questioning whether Bloom Energy's fundamentals are real, I got to borrow a line from the legendary Terry Hatcher in Seinfeld. The real. And they're spectacular. Oh, Jerry in Florida. Jerry.

[Caller/Listener]

Jim, I saw your interview with the CEO of Aero Environment and I invested in av. I'm curious now how serious the radar problem is and what kind of impact that's going to have on their bottom line, their revenue and their backlog that they have with the government contracts that they hold.

[Jim Cramer]

Well, look, it's a great question. I think that they. Look, I think that in the end this is a company that's loved and provides a valuable service and they're going to fix it. You know, I like this company from when it was literally like a teenager and then when it, when it was like 100, I said buy it. I can't back away from it because of that problem. I think that this company is a very good company, very well run. The data center build out has been terrific for energy players like Bloom and you don't have to question their fundamentals either. Now there's much more money, including industrial. Another winner. Mike, we're going to talk to CEO of Elanco Animal Health moving higher today on earnings humanization of pet steam back in fashion. I'm going to sit down with CEO then. The enterprise software space has been disrupted by AI as I keep talking about. But I've got to get you on my page here. So I'm going to give you my forecast on how I think things could shake out. And of course, all your calls. Rapid Fire, tonight's edition of the Lightning Round. So stay with Creamer. I love a good comeback story. Right now, there's a great one playing out in Elanco Animal Health. That's a veterinary medicine company spun up by Eli Lilly. All the way back. 2018 stock struggled to gain traction for a long time, but it's now up 137% over the past 12 months, almost 70% since the start of 2026. Tehlanca rallied another 6.6% after reported a very strong quarter 12% revenue growth driven by strength in both pet health and farm animals. And a 2 cent earnings beat off 11 cent basis. At the same time, management gave a very solid full year forecast. This is a growth company people. I want to know if it can keep running. Let's check in with Jeff Simmons, he's the President CEO of a Lanco Animal Health to find out. Mr. Simmons, welcome back to Matt Money.

[Jeff Simmons, CEO of Elanco Animal Health]

Great to be here, Jim. Thank you.

[Jim Cramer]

All right, so Jeff, when we first met each other, we met each other on the floor, floor of the exchange. I looked your company over and I said wow, Eli Lilly really did not want to own a Lanco. There's a lot of things that have to be done. You have to get some growth. You have to clean up the balance sheet. I was worried about animal health. You had a division about Aqua. I don't know, you changed everything. Congratulations.

[Jeff Simmons, CEO of Elanco Animal Health]

Hey, thank you. Yeah, we just reported a great historical year and as I've told you from the beginning it's been about growth, innovation and cash. And that's where energy has been and Elanco is transitioned into a sustainable growth company. And it's been a two and a half years of consistent growth. And we're excited, we committed Jim in our, in our future the next three years to mid single digit revenue, high single digit EBITDA and low double digit eps. And we're excited and our investors have, have had a really good time with us focused on this growth, innovation in cash.

[Jim Cramer]

Let's do this. Let's consider you like a human health company because I think that the people then be as excited about Elanco as I am a human health company. We know they come up with new drugs. The drugs are big. They try to come up with blockbusters all the time. They grow the total addressable market. They go overseas. Your company does look like a typical human health care company. So maybe we look at it like that.

[Jeff Simmons, CEO of Elanco Animal Health]

Well look, I think we have the best of pharmaceuticals. We have a regulated business. It's science based. There's a high bar of entry, no question. But we also bring this brand element, Jim, that I think makes us when things go up, patent, they continue to grow. We have that in farm and in pat. And so there's, there's pet owners and protein companies are also brand loyal and we're a cash market so not a payer market. So it makes it very durable. And I believe that, you know, that's what sets us up to be such a compelling industry. And really, yes, innovation does Matter. And Elanco is at the cusp of something very historical. We have six blockbusters approved in major markets. And these are major markets. We've got best medicine and we're taking share. And I think that's what got people excited about the fourth quarter and 2025. Freelance.

[Jim Cramer]

Give us a couple. Because those of us who are pet owners may be using this stuff. And I know that. I think you're absolutely right. We know the brands. We don't know the brands of human, but we know for our dogs.

[Jeff Simmons, CEO of Elanco Animal Health]

Yeah. The biggest one is parasiticides.

[Jim Cramer]

Right.

[Jeff Simmons, CEO of Elanco Animal Health]

That is the big market. So that's the tick, flea, heartworm, and guess what? That oral pill, that's. That's the fastest growing segment. It's growing at 30%. We took the most market share last year with Cridellio Quattro. Quattro, because there's four active ingredients. It's got four dimensions of differentiation. We got broader coverage, faster tick kill. And pet owners and veterinarians have resonated with that. And I'll point to one index that even your pet owners will understand, and that is, we are winning the puppy. The puppy index is more. Vets are putting puppies on Quattro.

[Jim Cramer]

Why?

[Jeff Simmons, CEO of Elanco Animal Health]

Because of the confidence in it. And I always say, if you get the puppy, you keep the dog. And that's a key one. The second area, derm.

[Jim Cramer]

Okay.

[Jeff Simmons, CEO of Elanco Animal Health]

An itching dog can break the bond of a pet owner.

[Jim Cramer]

Right.

[Jeff Simmons, CEO of Elanco Animal Health]

$2 billion market, probably.

[Jim Cramer]

What.

[Jeff Simmons, CEO of Elanco Animal Health]

What's the number one reason people go to the vet is an itching dog. We've got a product, Zenrelli. It's in 40 countries. We got 40% market share in year one in Brazil. It's acting like a first to market product, Jim. And then we just got approved and are going to launch next quarter our second derm product, Befrena. That will go after the monoclonal antibody market. So, you know, parasiticides, derm, we're coming with pain. And then look, we reported today a $200 million brand that broke over 200 million in the beef market.

[Jim Cramer]

Right.

[Jeff Simmons, CEO of Elanco Animal Health]

And this protein revolution is real. It is here and it is key.

[Jim Cramer]

Well, let's talk about that. The accelerating global animal protein consumption projected to grow up 5% annually in the US alone. GOP Dash 1 usage, muscle retention, aging population, overwhelming consumer demand. And you are doing something to meet that demand.

[Jeff Simmons, CEO of Elanco Animal Health]

Yeah, we are number one right now in the US in beef and in poultry and in swine. We took a lot of market share. Our US business grew 17% in farm animal. I spent A lot of time. The last three months in boardrooms talking to protein owners. There is a protein revolution going on. You're exactly right. The dietary guidelines can more than double the use. You know, there's going to be 20% more people over 60 years of age. I think the new disease is muscle retention. And yes, even linked to our old parent GLP use, you know, we're seeing 40 to 50% more protein consumption. How does that relate to our business? It comes back to, hey, protein has never been more valuable. Look at dairy. Dairy grew 4% in the fourth quarter alone as an industry and they invested $10 billion. From shakes to cottage cheese to cheese. It's changed. Farm animal is 25 billion of this $40 billion industry and we're going to grow to 60 billion as an industry. 20 billion more. Farm animal will have its share of that.

[Jim Cramer]

But Jeff, I keep reading about how small the cattle herd is and how high the cattle prices are. Can you still grow if the cattle is herd is, is steady and not grow?

[Jeff Simmons, CEO of Elanco Animal Health]

One of our six blockbusters is experior. Experior is used in the beef industry in US and Canada. Grew 80% last year. What it does, Jim, is when you have less cattle numbers, you've got to actually, you know, make the most and maximize the cattle you have. So the health matters, the efficiency matters. And cattlemen are actually making money with a shortage of herd here. But we're helping them make sure they can produce as much protein as possible. And that's been demonstrated with this innovation. And you know, we also announced today, you know, continued acquisitions and growth of our dairy side of the business because dairy is, I think, another extremely fast growing protein that, that is going to, you know, show, show great growth going long term.

[Jim Cramer]

Some, some of the people in my office want to know about Punch the Monkey. I've felt that that was not appropriate, but I know you long enough to think that you may actually know something about Punch the Monkey.

[Jeff Simmons, CEO of Elanco Animal Health]

I'll stick to our business and the basket of innovation and what we've got going on.

[Jim Cramer]

I think, look, I think that's a shrewd choice.

[Jeff Simmons, CEO of Elanco Animal Health]

Yeah, well, look, I think, you know, the message that we've been, you know, really focused on with our investors is these are major markets. As I mentioned, cattle, both bear, you know, dairy and beef, the Parasiticide and Durham market. And I'll come back to something you and I have talked about. The humanization of pets. You know, we are getting to what matters most to consumers. The consumer is shifting and you know, we hit it. You know, from diets to dogs and the protein shift has happened that we just talked about. On the, on the pet side, the humanization of pets is globalizing, Jim. 70% of puppies is actually outside, outside of the U.S. so the globalization. A global company like Elanco is capitalizing on double digit growth outside of the US in the pet market. And then convenience. A big statistic right now is 40% of pet care is under subscription. And Elanco took five years ago and said, hey, we are going to build an Omni Channel business. We can reach more pet owners where they want to shop at the price point they want to shop at. With the acquisition of Bayer, we're best positioned for this trend. The pet owner wants convenience and the pet owner is globalizing. And to me we're best set up as any company to take advantage of that.

[Jim Cramer]

Well, I know because of you, I actually we asked for Lenko products. We switched. By the way. I'm not going to, you know, I don't mean to throw the other guy under the bus but we switch and I don't know, the dog seem happy. What do I know? But it's better than an unhappy dog and it's better than an itchy dog. I want to thank Jeff Simmons, presidency of a Ronco Animal Health. Fabulous turnaround, sir. Thank you for coming on the show.

[Jeff Simmons, CEO of Elanco Animal Health]

Thanks, Jim. Thank you very much.

[Jim Cramer]

May I be back after the break.

[Show Producer/Host Voiceover]

Coming up, you've got questions. Kramer's got the answers. Get charged up for a fast fire lightning round. Next,

[Jim Cramer]

Before we start the lighting round, a reminder, don't miss out on our President's Day special. Join me in the CNBC Investing Club to get access to our morning meetings and key market insights. You don't want to miss something else. You would have special VIP access to our world famous monthly meetings. They really are helpful. People love them. It's a market masterclass. In fact, we got a big one coming up this Friday at noon. How to get involved, Scan the QR code or head to cnbc.comkramer club to become a member. Now I think you'll love it. And now it is time for the lightning round. Rolson myself syndrome. My step is going to plan itself and then the lightning round is over. Are you ready, Ski Daddy? Time for the light round. Occasionally. We'll start with Mark in Wisconsin.

[Caller/Listener]

Mark, Dr. Kramer, thank you for taking my call.

[Jim Cramer]

Pleasure call.

[Caller/Listener]

I don't know what I got here. Whether this is a value stock or a value trap. What do you think of kicker KD Kyndrell Okay.

[Jim Cramer]

Kyndrell had some accounting issues this quarter. I therefore have to put it in the penalty box. We have to see what happens next quarter. It's too early to recommend the stock. That was a very tough quarter. Let's go to Rebecca in New York. Rebecca. Hi, Mr. Kratter.

[Caller/Listener]

I wanted to admit you so much

[Jim Cramer]

the past two weeks.

[Caller/Listener]

I'm sorry to read your book.

[Jim Cramer]

I love it. Thank you. You are a great writer. I feel like you spoke directly. Thank you. Is that Novo Nordisk? Oh, no. You don't want to be Novo Nordisk. You want to be like Lily. Novo Nordisk is really good at getting cutting prices. Eli Lilly's great at making drugs. Let's go to Bill in Florida. Bill. Hey, Jim.

[Jeff Simmons, CEO of Elanco Animal Health]

Booyah.

[Jim Cramer]

Thank you. We. We miss you during the Olympics. My stock, is it Gartner? Okay. Not a great quarter. And it's people worried about that. It's going to be anthropic that people can go after them too easily. We have to. We're going to have to say no to that. Let's go to Jim in Illinois. Jim.

[Caller/Listener]

Jimmy.

[Jim Cramer]

Boo yah from the land of Lincoln, where we love Kramer a lot more than the idea of the third moving to Indiana. I'm so glad because I think that I am a little more popular than that idea. What's going on?

[Caller/Listener]

Okay. The stock I've got for you today is the Davis Center Infrastructure Services grade. I bought it for 172 on May 23rd, nine months ago.

[Jim Cramer]

And if to 214% of upside.

[Caller/Listener]

I want to know what to do with Powell Industries.

[Jim Cramer]

I want to know what you tell me to do. Man. If you nailed Powell there, we did like the stock. I want you to take off one third of it. Then you're playing the rest of the house's money. And don't ever touch it again. And that, ladies and gentlemen, is the conclusion of the Lightning Round.

[Show Producer/Host Voiceover]

The Lightning Round is sponsored by Charles Schwab. Coming up, Cramer's zeroing in on the situation in software stocks and analyzing just how much more pain AI can inflict on the sector.

[Jim Cramer]

Next. For over a decade, we loved enterprise software companies. Companies that made other companies more efficient, made them better. These outfits made themselves integral to the workplace. They seem to do well in both good times and bad. Secular growers, we called them. I always view these software companies as a bit ethereal, hard to understand. What did workday do to make human resources so much better? How could servicenow go from helping with onboarding to piloting the entire ship? Could salesforce's exciting agent force makeup for decline in seats from the rest of the business. Most investors simply saw these companies save their clients money and made a fortune for the shareholders. We, when we had most of the non revenue generating parts of an office, automated new companies were created that showed you how to use your data more efficiently. They prosecuted the data and we needed to protect the data the companies generated. So we bought very expensive cybersecurity stocks. These companies would try to get long term contracts, maybe four years with almost automatic price increases. And they really got any price price pushback. Why? Well, because the cost savings remain impossible. Ignore sticky revenues, virtuous circle for all. Of course, these software stocks were never cheap by traditional metrics. They were rarely valued on earnings per share. They traded more on things like rule of 40 where you judge a company on its revenue growth rate plus its profit margin, usually the EBITDA margin. And if they add up to more than 40, we got a winner. We look at how much annual recurring revenue they had. We looked at their total addressable market and how they were attacking it. We looked to see if this kind of company was really sticky, did it have a moat. Often they paid their employees with stock, which meant that if they were turned profitable, it might be because of the mirage of stock being paid instead of cash. As long as their share prices were going higher, I mean, who cared? No problem. The faster these companies grew the revenue, the more we were willing to pay for them. There seemed to be an endless new supply of these things too. And they were often lapped up by funds that feasted on the fastest secular growers. A whole host of funds would pay anything for these enterprise software players. The same funds over and over. Oh, and if the company stumbled, well, we had these private equity firms that loved acquiring the fallen angels. Companies like Thoma, Bravo Vista Equity Partners who figured out how to package these software outfits, merge the companies in every at least fine capital effortless. When they brought the public again, they were more polished. The stocks would pop right out of the gate. Mainly because these IPOs were so small. It was a can't miss situation. And the whole cohort was almost always a market leader. And then out of nowhere we got accelerating computing and artificial intelligence. All these software companies were based on writing code, but the AI platforms can write code themselves. It's the one thing, look, they do it great, better and faster than we can. Cost a lot less than software engineers in a year. Everything, the whole edifice was attacked. And even those enterprise software companies that have continued to mostly report Good numbers except for workday this evening. Well, the clients are no longer so confident or receptive to order long term deals. One company in particular, Anthropic, as I said at the top of the show, decided to go after Anthropology, one of these businesses, and that's what's happening now. Anthropic caused the clients to ask for shorter contracts. So they can try Claude or we shift over to something else that might be better. Right now, the managers of Enterprise Software and the venture capital and private credit and private equity firms that back them, they're all in shock. They hope Anthropic doesn't come after them because if that happens, their stocks would get crushed in the end. There's way too much money in the enterprise. So first base and we way too many companies now they're being disrupted by AI. You know what it is? It's a Humpty Dumpty situation. I don't know where it goes. I do know that Alpha specialize in lending to the software companies that have gone from public to private are being obliterated. I have no answers about what will happen to the enterprise software players or their financiers. I do know this. My forecast for all is pain and the losses are far from over. So use this bounce to whiten up. I like to say there's always a bull market somewhere and I promise try to find it just for you. Right here on Bad Money. I'm Jim Cramer. See you tomorrow.

[Advertiser/Commercial Announcer]

All opinions expressed by Jim Cramer on this podcast are solely Kramer's opinions and do not reflect the opinions of CNBC or its parent company or affiliates and may have been previously disseminated by Kramer on television, radio, Internet or another medium. You should not treat any opinion expressed by Kramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion. Kramer's opinions are based upon information he considers reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy and it should not be relied upon as such. To View the full Mad Money disclaimer, please visit cnbc.com madmoneydisclaimer before you set

[Jim Cramer]

health goals for the year, you need to set a baseline.

[Show Producer/Host Voiceover]

With LabCorp On Demand's suite of science backed health tests, you'll get a more

[Jim Cramer]

complete picture of your health. Whether you want insights about hormone health

[Show Producer/Host Voiceover]

or nutrient levels, testing provides data that

[Jim Cramer]

can help shape your wellness goals and track your progress over the course of the year. To get 15% off select tests, visit ondemand.labcorp.com podcast use code podcast for 15%

[Show Producer/Host Voiceover]

off go test yourself.